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B reast cancer is the most common cancer that affects women and the leading cause of cancer 
death among them [1].  Surgery is the treatment of 
choice for patients with breast cancer,  and it generally 
includes sentinel lymph node biopsy or axillary lymph 
node dissection (ALND).  The axillary surgical approach 
has postoperative morbidity,  including early or long-
term complications such as axillary web syndrome 
(AWS),  decreased range of motion (ROM) of the arm or 
shoulder,  numbness,  pain,  and lymphedema [2-6].
AWS has been characterized as the presence of a 
visible and palpable stretched band underneath the skin,  
which is taut and painful during shoulder flexion or 
abduction [7-10].  The cords originate in the axilla and 
extend to the medial and upper portions of the arm to 
the anterior portion of the elbow [8].  Several studies 
have reported that AWS occurs after a delay of one week 
post-surgery and resolves within the following three 
months [7 , 11-15].  AWS has been reported to nega-
tively affect shoulder ROM and lymphedema develop-
ment [6 , 16].  Risk factors for AWS may include exten-
sive surgery [6 , 17],  younger age [5 , 17],  lower body 
mass index (BMI) [5 , 14 , 17],  ethnicity,  and healing 
complications [5 , 6].  In Japan,  there have been no 
studies on whether AWS is related to decreased ROM of 
the arm or shoulder,  or decreased quality of life (QOL).  
In addition,  the risk factors for the development of 
AWS in Japan are unclear.
In this study,  we examined whether AWS in patients 
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In this study,  we examined whether axillary web syndrome (AWS) in patients with breast cancer following axil-
lary lymph node dissection affects range of motion (ROM),  upper extremity function,  and quality of life 
(QOL).  The risk factors for AWS were also evaluated in a total of 238 consecutive breast cancer patients follow-
ing axillary lymph node dissection.  At 1,  2,  and 3 months after surgery,  there were no significant differences 
between the AWS group and the non-AWS group in upper-limb function or QOL.  At 2 months after surgery,  
shoulder flexion and abduction ROM were significantly higher in the AWS group than in the non-AWS group 
(p< 0.05).  Self-training time at home was not significantly different between the groups at 1,  2,  or 3 months.  
Only age was a significant predictor of AWS at 1 month after surgery (p< 0.05).  The AWS group in the present 
study did not have worse results for shoulder joint ROM,  upper-limb function,  and QOL than the non-AWS 
group.  Younger age should be useful for predicting the development of AWS in the early postoperative period.
Key words:  breast cancer,  axillary web syndrome,  age,  upper limb function,  quality of life
Received March 9, 2020 ; accepted October 1, 2020.
＊Corresponding author. Phone : +81-88-850-2311; Fax : +81-88-850-2323
E-mail : akezakiteru@yahoo.co.jp (Y. Akezaki)
Conflict of Interest Disclosures: No potential conflict of interest relevant 
to this article was reported.
with breast cancer following ALND affects ROM,  upper 
extremity function,  and QOL.  Risk factors for AWS 
were also evaluated.
Methods
Patients and methods. The subjects of this study 
were 238 consecutive breast cancer patients who 
underwent ALND at our hospital between November 
2013 and December 2016.  All subjects were female.  
Age,  BMI,  level of lymph node dissection (Level 1,  
Level 2,  and higher),  preoperative chemotherapy (yes 
or no),  self-training time at home,  shoulder ROM,  
upper extremity function (disabilities of the arm,  
shoulder and hand [DASH]),  and QOL (EORTC QLQ- 
C 30) were evaluated.
Ethical approval. This study was approved by the 
Shikoku Cancer Center Ethics Committee,  and written 
informed consent was obtained from each participant 
(Approval No. 2018-45).
Rehabilitation program. As preoperative reha-
bilitation during hospitalization,  guidance was given on 
upper extremity exercises using a prerecorded video on 
a DVD.  In the video,  an instructor demonstrated 
proper movement of the upper extremity.  Postoperative 
rehabilitation was started from the first and second 
postoperative days with exercise beyond the elbow joint.  
From the third postoperative day to the day of drain 
withdrawal,  upper extremity ROM exercises were per-
formed within 90 degrees of shoulder joint flexion and 
abduction.  After removal of the drain,  shoulder ROM 
was not restricted,  and exercise of the upper extremity 
and activities of daily living (ADL) were adjusted 
according to the degree of pain.  Patients were also 
instructed to perform self-training at home with the 
DVD at least once a day after discharge from the hospi-
tal.
Patients who developed AWS at discharge or at 1,  2,  
or 3 months after surgery were instructed to raise the 
shoulder joint while flexing the elbow to extend the 
axilla if they had a strong sense of tension or pain in the 
upper limbs during the shoulder raising movement in 
the elbow extension position.  In ADL,  when partici-
pants experienced a sense of tension in the elbow exten-
sion position,  they were instructed to perform the 
movement in the elbow flexion position if possible.
Axillary web syndrome assessment. Patients were 
defined as having AWS in the operated upper extremity 
when a cord of tissue was present at 1 , 2,  or 3 months 
after surgery.
We evaluated AWS as follows:
・Patients were assessed as having AWS when a 
cord of tissue was present in the axilla,  upper limbs,  or 
trunk during maximum shoulder abduction of the 
operated upper extremity [18].
・Patients were assessed as having AWS even in the 
absence of local pain when a cord of tissue was present 
in the operated upper extremity [18].
・Patients were assessed as having AWS even when 
there was no restriction in their shoulder ROM when a 
cord of tissue was present in the operated upper extrem-
ity [18].
In this study,  the patients were categorized into the 
AWS group and the non-AWS group.
Quality of life assessment. QOL was measured 
using an EORTC QLQ-C30 questionnaire [19].  This 
questionnaire includes items relating to global health 
status,  functional scales (physical,  role,  emotional,  
cognitive,  and social),  and symptom scales (fatigue,  
nausea/vomiting,  pain,  dyspnea,  insomnia,  appetite 
loss,  constipation,  diarrhea,  and financial difficulties).  
EORTC QLQ-C 30 measurements were evaluated at 1,  
2,  and 3 months after surgery.
Shoulder range of motion test. The ROM test was 
used to measured active shoulder flexion and abduction 
1,  2,  and 3 months after surgery.
Evaluation of disabilities of the arm, shoulder and 
hand. The DASH is a 30-item disability/symptom 
scale concerning the patient’s health status during the 
preceding week [20].  The 30 items consist of 21 items 
about the degree of difficulty in performing different 
physical activities due to arm,  shoulder,  or hand prob-
lems,  5 items about the severity of the symptoms,  and 
4 items concerning the effects of the upper extremity 
problem on social activities,  work,  sleep,  and self- 
image.  DASH was administered at 1,  2,  and 3 months 
after surgery.
Self-training time at home. Self-training time at 
home was investigated at 1 month,  2 months,  and 3 
months after surgery.  The one month measurement 
included all self-training from discharge to 1 month 
after surgery,  the 2 month measurement included all 
self-training from 1 month to 2 months after surgery,  
and the 3 month measurement included all self-training 
from 2 months to 3 months after surgery.  The average 
daily self-training time at home was examined within 
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each period.
Statistical analysis. For shoulder joint ROM,  
DASH,  and EORTC QLQ-C 30 comparisons between 
the AWS and non-AWS group were evaluated using 
Student’s t-test,  the chi-squared test,  and the Mann-
Whitney U test.  To identify factors predictive of AWS at 
1,  2,  and 3 months after surgery,  univariate analysis 
was carried out using Student’s t-test,  the chi-squared 
test,  and the Mann-Whitney U test,  with age,  BMI,  
level of lymph node dissection,  and preoperative che-
motherapy as variables.  Next,  for items with p < 0.1 on 
univariate analysis,  logistic regression analysis was used 
to identify the best independent predictor of AWS at 1,  
2,  and 3 months after surgery.
All statistical tests were two-sided,  with p < 0.05 
considered significant.  Statistical analyses were per-
formed using IBM SPSS Statistics Version 22.0 (IBM,  
Tokyo).
Results
Occurrence of axillary web syndrome. There 
were 55 , 47,  and 23 patients at 1,  2,  and 3 months,  
respectively,  in the AWS group.  There were 183 , 191,  
and 215 patients at 1,  2,  and 3 months,  respectively,  in 
the non-AWS group.
Comparisons of the shoulder joint range of motion, 
DASH, and EORTC QLQ-C 30 between groups.
Table 1 shows the differences in self-training time at 
home,  shoulder ROM,  DASH,  and QLQ-C 30 
between the AWS and non-AWS groups at 1,  2,  and 3 
months after surgery.
At 1 month after surgery,  there were no significant 
differences between the AWS and the non-AWS groups 
in self-training time at home,  shoulder ROM,  DASH,  
or QLQ-C 30.
 At 2 months after surgery,  shoulder flexion ROM 
and abduction ROM were significantly higher in the 
AWS group than in the non-AWS group (p < 0.05).  Self-
training time at home,  DASH,  and QLQ-C 30 were not 
significantly different between the groups.
At 3 months after surgery,  there were no significant 
differences between the AWS and non-AWS groups in 
self-training time at home,  shoulder ROM,  DASH,  or 
QLQ-C 30.
Factors predicting axillary web syndrome. On 
univariate analysis,  age showed a significant difference 
between the AWS and non-AWS groups at one month 
after surgery (Table 2).  Age was the only significant 
predictor of AWS at one month after surgery (p < 0.05) 
(Table 3).  There were no items that showed significant 
differences at two and three months after surgery.
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Table 1　 Comparison of range of motion test,  upper extremity function,  and QOL between the AWS and non-AWS groups at one,  two,  
and three months after surgery
Variable
One month (n=238) Two months (n=238) Three months (n=238)











Self- training time (times) a) 24.4±19.0 26.0±23.0 0.921 18.4±24.0 15.2±14.0 0.685 7.0±8.6 11.0±12.0 0.152
DASH (scores) a) 23.2±11.6 21.5±13.9 0.187 20.0±16.1 18.6±15.4 0.659 15.6±12.4 15.4±13.1 0.790
ROM (degrees) a)
　Shoulder flexion 142.6±17.8 137.8±18.5 0.086 156.5±11.0 149.0±16.0 0.002 153.3±12.5 154.5±14.2 0.484
　Shoulder abduction 137.5±23.8 134.2±24.6 0.421 156.0±17.2 147.9±20.5 0.008 155.0±15.2 154.7±17.5 0.756
QLQ-C 30 (scores) a)
　Global health status/QOL 62.3±19.1 64.2±21.3 0.506 65.9±21.9 62.9±22.5 0.357 59.8±22.8 66.4±24.2 0.175
　Physical function 85.3±11.1 84.3±14.1 0.939 85.2±14.1 86.3±14.0 0.668 89.0±7.7 87.5±12.4 0.923
　Role function 73.5±19.0 76.1±19.0 0.355 75.9±26.5 77.4±22.9 0.945 81.9±15.8 81.8±22.8 0.542
　Emotional function 76.9±16.6 76.6±19.6 0.729 82.6±17.3 82.7±17.1 0.979 88.8±11.7 85.2±16.2 0.439
　Cognitive function 86.4±14.4 86.0±16.7 0.793 83.3±17.0 84.1±18.6 0.616 86.2±15.6 84.8±18.4 0.924
　Social function 79.4±21.7 81.9±21.0 0.423 75.2±26.5 80.6±20.7 0.307 82.6±23.3 84.2±21.8 0.840
　Fatigue 26.5±16.9 27.3±19.8 0.885 27.9±17.2 27.1±20.5 0.558 29.0±19.2 25.6±18.4 0.436
　Nausea/Vomiting 1.5±7.4 1.7±6.5 0.609 5.6±14.2 4.5±11.8 0.537 5.8±17.8 3.8±11.4 0.782
　Pain 31.6±14.4 29.3±16.9 0.214 16.3±14.0 22.0±18.5 0.078 14.5±11.6 19.4±20.6 0.473
　Dyspnea 7.9±14.3 10.3±16.6 0.402 14.8±19.5 11.5±20.0 0.207 11.6±19.1 12.6±18.7 0.732
　Insomnia/sleep 20.0±20.9 21.0±23.6 0.967 21.5±24.8 24.4±27.3 0.600 17.4±17.0 20.8±23.7 0.749
　Appetite loss 7.3±16.6 6.7±15.6 0.912 16.3±24.2 13.4±22.3 0.441 14.5±24.3 12.1±19.6 0.880
　Constipation 12.7±18.7 12.0±18.3 0.734 21.5±30.3 17.8±22.8 0.772 23.2±32.5 15.3±21.9 0.319
　Diarrhea 6.1±18.2 3.9±10.7 0.744 7.4±15.7 10.8±22.4 0.512 7.2±17.3 6.8±16.8 0.895
　Financial difficulties 13.3±19.9 19.2±25.0 0.268 22.2±26.6 17.8±22.5 0.374 18.8±22.1 14.3±20.9 0.192
Discussion
AWS has been reported to occur in 5.2-72% of 
patients following ALND [17 , 21].  Several studies 
showed that AWS occurred 1-8 weeks after axillary sur-
gery [8 , 16],  and AWS has been shown to resolve within 
three months after surgery [8 , 22].  In addition,  physio-
therapy for AWS has been shown to shorten the natural 
course of the syndrome to 6-8 weeks [14].  In the pres-
ent study,  the rate of AWS was 23.1%,  19.7%,  and 
9.7% at 1,  2,  and 3 months after surgery,  respectively;  
the rate showed a gradual decrease.  After surgery,  the 
present breast cancer patients were encouraged to per-
form self-training at home,  but AWS occurred even 
three months after surgery.  Therefore,  patients may 
need exercise therapy and upper extremity function 
assessment beyond 3 months after discharge for breast 
cancer surgery.
Several studies showed reduced active shoulder flex-
ion and abduction in patients with AWS [16 , 23].  In our 
research,  there were no significant differences in active 
shoulder flexion ROM and abduction ROM between the 
AWS group and the non-AWS group at 1 and 3 months 
after surgery.  At 2 months after surgery,  the ROMs of 
shoulder flexion and abduction were significantly 
higher in the AWS group than in the non-AWS group.
In other studies,  rehabilitation interventions have 
been reported to be effective in improving AWS [24].  
Patients with AWS tend to reduce the time they spend 
exercising due to a sense of tension and pain.  In the 
present study,  the patients were instructed to perform 
vigorous rehabilitation at discharge and 1,  2,  and 3 
months after surgery.  Also,  patients who developed 
AWS at 1 , 2,  and 3 months after surgery were given 
advice on exercise and ADL according to their condi-
tion.  As a result,  self-training time at home showed no 
significant differences between the AWS and non-AWS 
groups at 1 , 2,  and 3 months after surgery.  This means 
the AWS group did not show a decrease in shoulder 
ROM compared to the non-AWS group at 1 and 3 
months after surgery.  Furthermore,  an increase in 
shoulder ROM was observed in the AWS group at 2 
months after surgery.  Even patients who developed 
AWS may have also attained a good result by self-train-
ing at home.
Studies have reported on functional activities after 
breast surgery,  though none related these findings to 
AWS [25 , 26].  In our research,  there was no significant 
difference in the DASH between the AWS and non-
AWS groups.  AWS causes symptoms such as a sense of 
tension or pain on shoulder flexion while extending the 
elbow and axilla.  In raising the shoulder joint,  elbow 
joint flexion reduces AWS symptoms.  In the DASH 
assessment,  many of the items related to the degree of 
difficulty in performing different physical activities due 
to arm,  shoulder,  or hand problems can be performed 
even in elbow flexion.  Thus,  this may explain why the 
present study found no significant differences between 
the AWS and non-AWS groups.
Several studies have shown that AWS caused patient 
anxiety and fear due to poor understanding of the com-
plication [7 , 24].  In this study,  QOL was not signifi-
cantly different between the AWS and non-AWS groups 
at 1 to 3 months postoperatively.  There were no signifi-
cant differences in upper extremity function between 
groups.  Therefore,  in the patients of the present study,  
the effect on QOL of the occurrence of AWS was likely 
low.
The risk factors for developing AWS have been 
reported to be ALND,  lower BMI,  and younger age 
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Table 3　 Risk factors of AWS determined by logistic regression 
analysis at one month after surgery
Variable Odds ratio (95%CI) p value
Age 0.961 (0.935-0.987) 0.003
Table 2　 Results of univariate analysis to extract risk factors for AWS at 1 month after surgery
Variable AWS group (n=55) Non-AWS group (n=183) p value
Age (y) a) 52.0±11.0 57.7±12.4 0.002
BMI (kg/m2) a) 22.5±3.6 23.2±4.0 0.290
Time for drain removal (days) a) 5.0±1.8 4.9±1.5 0.982
Level of lymph node dissection (Ⅰ/Ⅱ/Ⅲ) b) 41/10/4 143/25/15 0.634
Resection of pectoralis minor muscle (yes or no) b) 1/54 8/175 0.385
Neoadjuvant chemotherapy (yes/no) b) 19/36 50/133 0.302
[5 , 6 , 14 , 17].  It is possible that age and BMI are related,  
since older people are more likely to have a higher BMI 
[14].  In the present study,  the only risk factor for 
developing AWS at one month postoperatively was age,  
and no factors were observed at 2 and 3 months in 
breast cancer patients following ALND.  In patients with 
breast cancer after ALND,  the reason why only young 
age affects AWS is not clear,  but younger age may be 
useful for predicting the development of AWS in the 
early postoperative period.  Also,  in this study,  age was 
not seen as a factor that was linked to the occurrence of 
AWS at 2 or 3 months post-surgery.  AWS showed a 
tendency of gradual improvement in the three months 
following surgery.  Age can affect the early occurrence 
of AWS but may not be a factor linked with improving 
AWS.
There were some limitations associated with this 
study.  First,  because all subjects were patients who had 
participated in the Rehabilitation program for three 
months,  our results do not reflect the effect on patients 
who do not participate in a Rehabilitation program.  
Second,  in our research,  the effect of AWS was exam-
ined in patients with breast cancer,  but a useful method 
for preventing and improving AWS remains to be clari-
fied.  Third,  this research was conducted at a single 
facility,  and the results of collaborative research with 
other research facilities could be different.
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